Please use this identifier to cite or link to this item: https://doi.org/10.1186/2051-5960-2-4
DC FieldValue
dc.titleGeneration of iPSC lines from archived non-cryoprotected biobanked dura mater
dc.contributor.authorSproul, A.A
dc.contributor.authorVensand, L.B
dc.contributor.authorDusenberry, C.R
dc.contributor.authorJacob, S
dc.contributor.authorVonsattel, J.P.G
dc.contributor.authorPaull, D.J
dc.contributor.authorShelanski, M.L
dc.contributor.authorCrary, J.F
dc.contributor.authorNoggle, S.A
dc.date.accessioned2020-10-30T01:57:01Z
dc.date.available2020-10-30T01:57:01Z
dc.date.issued2014
dc.identifier.citationSproul, A.A, Vensand, L.B, Dusenberry, C.R, Jacob, S, Vonsattel, J.P.G, Paull, D.J, Shelanski, M.L, Crary, J.F, Noggle, S.A (2014). Generation of iPSC lines from archived non-cryoprotected biobanked dura mater. Acta Neuropathologica Communications 2 (1) : 4. ScholarBank@NUS Repository. https://doi.org/10.1186/2051-5960-2-4
dc.identifier.issn20515960
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/182029
dc.description.abstractBackground: Induced pluripotent stem cells (iPSCs) derived from patients with neurodegenerative disease generally lack neuropathological confirmation, the gold standard for disease classification and grading of severity. The use of tissue with a definitive neuropathological diagnosis would be an ideal source for iPSCs. The challenge to this approach is that the majority of biobanked brain tissue was not meant for growing live cells, and thus was not frozen in the presence of cryoprotectants such as DMSO. Results: We report the generation of iPSCs from frozen non-cryoprotected dural tissue stored at -80°C for up to 11 years. This autopsy cohort included subjects with Alzheimer's disease and four other neurodegenerative diseases. Conclusions: Disease-specific iPSCs can be generated from readily available, archival biobanked tissue. This allows for rapid expansion of generating iPSCs with confirmed pathology as well as allowing access to rare patient variants that have been banked. © 2014 Sproul et al.; licensee BioMed Central Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20201031
dc.subjecthomeodomain protein
dc.subjectmembrane antigen
dc.subjectNANOG protein, human
dc.subjectoctamer transcription factor 4
dc.subjectproteoglycan
dc.subjectstage specific embryo antigen
dc.subjectstage-specific embryonic antigen-4
dc.subjectTRA-1-60 antigen, human
dc.subjectAlzheimer disease
dc.subjectanimal
dc.subjectcell differentiation
dc.subjectcell proliferation
dc.subjectcytology
dc.subjectdata base
dc.subjectdegenerative disease
dc.subjectdura mater
dc.subjectfibroblast
dc.subjecthuman
dc.subjectmetabolism
dc.subjectmouse
dc.subjectpathology
dc.subjectphysiology
dc.subjectpluripotent stem cell
dc.subjectpostmortem change
dc.subjectskin
dc.subjecttransformed cell line
dc.subjectvirology
dc.subjectAlzheimer Disease
dc.subjectAnimals
dc.subjectAntigens, Surface
dc.subjectCell Differentiation
dc.subjectCell Line, Transformed
dc.subjectCell Proliferation
dc.subjectDatabases as Topic
dc.subjectDura Mater
dc.subjectFibroblasts
dc.subjectHomeodomain Proteins
dc.subjectHumans
dc.subjectInduced Pluripotent Stem Cells
dc.subjectMice
dc.subjectNeurodegenerative Diseases
dc.subjectOctamer Transcription Factor-3
dc.subjectPostmortem Changes
dc.subjectProteoglycans
dc.subjectSkin
dc.subjectStage-Specific Embryonic Antigens
dc.typeArticle
dc.contributor.departmentPATHOLOGY
dc.description.doi10.1186/2051-5960-2-4
dc.description.sourcetitleActa Neuropathologica Communications
dc.description.volume2
dc.description.issue1
dc.description.page4
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_2051-5960-2-4.pdf5.34 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons